Paratek Pharma Inc (PRTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,578 | 53,779 | 133,745 | 95,856 | 1,212 |
| Marketable Securities | 116,307 | 75,076 | N/A | N/A | N/A |
| Receivables | 5,889 | 323 | 745 | 4,434 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 40 |
| TOTAL | $160,486 | $132,100 | $142,417 | $101,329 | $1,252 |
| Non-Current Assets | |||||
| PPE Net | 1,711 | 1,188 | 779 | 49 | 33 |
| Intangibles | 971 | 1,844 | 2,178 | 5,643 | 0 |
| Other Non-Current Assets | 530 | 600 | 544 | 2,946 | 0 |
| TOTAL | $3,212 | $3,632 | $3,501 | $8,638 | $33 |
| Total Assets | $163,698 | $135,732 | $145,918 | $109,967 | $1,285 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,555 | 4,418 | 6,443 | 2,915 | 7,482 |
| Accrued Expenses | 4,964 | 9,566 | 11,583 | 826 | 4,783 |
| Other current liabilities | N/A | 56 | 2,476 | N/A | 22,373 |
| TOTAL | $16,789 | $20,412 | $20,502 | $3,741 | $34,829 |
| Non-Current Liabilities | |||||
| Long Term Debt | 59,186 | 38,974 | 19,565 | 0 | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 191 |
| Other Non-Current Liabilities | 5,245 | 4,754 | 4,611 | 11,002 | 73 |
| TOTAL | $64,431 | $43,728 | $24,176 | $11,002 | $224 |
| Total Liabilities | $81,220 | $64,140 | $44,678 | $14,743 | $35,053 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,443 | 24,286 | 17,609 | 14,418 | 1,570 |
| Common Shares | 28 | 23 | 17 | 14 | N/A |
| Retained earnings | -470,112 | -380,362 | -268,726 | -197,866 | -180,031 |
| Other shareholders' equity | -158 | -16 | 0 | 0 | 80,565 |
| TOTAL | $82,478 | $71,592 | $101,240 | $95,224 | $-33,768 |
| Total Liabilities And Equity | $163,698 | $135,732 | $145,918 | $109,967 | $1,285 |